Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer shells out $225mm plus contingent milestones for InnoPharma

Executive Summary

In the wake of its failed bid for AstraZeneca, Pfizer Inc. paid $225mm up front in cash and another $135mm in possible earn-outs to acquire privately held InnoPharma Inc., which specializes in generics and drug delivery.
Deal Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Payment Includes Cash
    • Full Acquisition

Related Companies